Hims & Hers, Ro, and LifeMD are the three online platforms most frequently compared for brand-name GLP-1 access, and each routes a qualifying patient’s prescription through the same NovoCare or LillyDirect manufacturer self-pay programs used across this category. Where they differ is everything around that prescription: how the intake actually runs, whether labs are included or left to you, how much support exists for an insurance-covered path, and how the membership itself is priced and canceled.
This comparison covers only that brand-name path, category by category, ending with an honest best-for verdict for each platform. None of the three should be defaulting a qualifying patient toward a compounded version of these drugs, which is not FDA-approved as a finished product — confirm the brand-name path directly during your own intake regardless of which platform you choose. Eligibility, dosing, titration, and how to manage any side effects are decisions for your prescriber, not something a comparison article can make for you.
This guide provides general information and is not medical advice. Talk to your prescriber or pharmacist before starting, stopping, or changing any medication, supplement, or device used alongside GLP-1 therapy.
Intake Model: Asynchronous Messaging vs. a Live Visit
Hims & Hers runs an online questionnaire reviewed by a licensed clinician, and most follow-ups happen through asynchronous messaging rather than a scheduled call. See Hims & Hers’ current plans. Disclosure: this is an affiliate link. GLP-1 Explained may earn a commission if you buy or sign up, at no extra cost to you. This is not medical advice.
Ro builds its membership around ongoing prescriber access rather than a one-time intake, and markets that standing relationship as part of what the membership price covers. Check eligibility with Ro. Disclosure: this is an affiliate link. GLP-1 Explained may earn a commission if you buy or sign up, at no extra cost to you. This is not medical advice.
LifeMD’s weight-management track sits inside a broader general-telehealth account, and because that same account supports primary and urgent care, patients more often describe a live clinician visit as part of the process rather than exclusively asynchronous messaging. Explore LifeMD’s program. Disclosure: this is an affiliate link. GLP-1 Explained may earn a commission if you buy or sign up, at no extra cost to you. This is not medical advice.
Whether Brand-Name Access Is Stated Plainly
All three platforms state that a qualifying patient is prescribed brand-name Wegovy or Zepbound rather than a compounded formulation, but the histories behind that statement are not identical. Hims & Hers’ consumer brand has also marketed compounded semaglutide and tirzepatide in the past and received an FDA warning letter over that marketing in September 2025, which is a specific reason to confirm the brand-name path explicitly during your own intake rather than assume it from the platform’s general marketing.
Ro is a Novo Nordisk partner for brand-name Wegovy access and states its clinicians will not prescribe a compounded product to a patient who qualifies for and wants the brand-name drug — a clearer stated position than either competitor, though it is still worth confirming for yourself. LifeMD states it can prescribe brand-name Wegovy or Zepbound through the same manufacturer programs, and because its business is not built primarily around a single GLP-1 product line the way some competitors’ marketing is, it has less history of compounded-product promotion to weigh — which is a point in its favor, not proof of anything about a specific intake.
Whichever platform you use, the single most useful check is watching whether the intake flow ever offers a compounded alternative as a faster or cheaper first option before showing you a brand-name price. A platform that leads with brand-name access and treats compounding as a separate, clearly labeled path, if it offers one at all, is behaving the way this comparison assumes; one that defaults you toward compounding during checkout is a reason to stop and look elsewhere.
Labs, Insurance, and Prior-Authorization Support
Ro leans hardest on labs as a selling point, including or coordinating them through a partner rather than leaving you to arrange a panel on your own — useful if you do not already have recent bloodwork. Hims & Hers’ lab requirements vary by state and can mean submitting your own recent results or using a local partner. LifeMD’s lab process is similar to Hims & Hers’ — existing results are sometimes accepted, otherwise a partner lab or at-home kit fills the gap — without the bundled emphasis Ro puts on it.
On insurance, all three are primarily self-pay businesses rather than in-network providers billing insurance directly for the medication. The meaningful difference is prior-authorization support: LifeMD’s prescribers routinely submit PA paperwork when a patient’s plan already covers weight-management drugs, which is a more active role than either Hims & Hers or Ro typically advertises. If your plan already covers Wegovy or Zepbound, ask directly which platform’s prescribers will actually do that paperwork, rather than assuming any of the three will handle it the same way.
Membership Pricing and Cancellation Terms
None of the three platforms prints a membership price stable enough to repeat here with any confidence — plan tiers and promotions change often enough that a specific number would be outdated within a quarter on any of them. What is durable is the structure: Ro’s bundled pricing tends to be visible earlier in the signup flow because it packages labs and access together; Hims & Hers’ full monthly total, membership plus drug cost, becomes clear later in the process; LifeMD’s membership sits inside a broader telehealth pricing structure that can include primary-care and urgent-care value beyond the GLP-1 piece specifically. Ask each platform for the combined membership-plus-drug total, in writing, before your first charge, regardless of which one you are considering.
All three run on auto-renewing memberships, and none makes cancellation as prominent as signup. The process on each is typically self-service through account settings, but the exact notice period and how a partial month is refunded varies and is worth confirming directly during your own signup rather than assuming it matches whatever the last platform you used did.
What to Look For
Brand-name access stated plainly, with compounding offered, if at all, as a separate and clearly labeled option. If any of the three platforms defaults you toward a compounded product before showing a brand-name price, that is not the comparison this guide describes.
The combined monthly total, not the advertised starting price for either piece alone. Membership or visit fee plus brand-name drug cost together, confirmed in writing before your first charge, whichever platform you choose.
A straight answer on prior-authorization support if you plan to use insurance. LifeMD’s prescribers routinely handle this; ask Hims & Hers and Ro directly whether theirs do the same before assuming it.
A cancellation process you have actually read, not just assumed. All three are auto-renewing memberships; know the notice period and refund policy before you need it, not after.
Useful Extras Worth Owning
These cover the realistic range of what actually helps, from the one item worth buying first to the small extra that makes the rest of the list easier to use.
A baseline reading you bring to whichever platform’s intake you end up completing, rather than one generated by whichever company you choose.
View on Amazon →A simple, low-cost habit tool that helps with a common early adjustment — staying ahead of dehydration — regardless of which of the three platforms is managing the prescription.
View on Amazon →Keeps injection days visible on one weekly schedule no matter which platform’s pharmacy partner ships the medication.
View on Amazon →Hims & Hers vs Ro vs LifeMD, Category by Category
| Category | Hims & Hers | Ro | LifeMD |
|---|---|---|---|
| Intake model | Async questionnaire + messaging | Membership with ongoing prescriber access | General telehealth account; visits often live |
| Brand-name access stated | Yes — confirm at intake given past compounded marketing | Yes — Novo Nordisk partner, states no compounding for qualifying patients | Yes — via NovoCare/LillyDirect, confirm at intake |
| Labs | Submit your own or use a local partner, varies by state | Included or coordinated through a partner lab | Existing results sometimes accepted, or partner lab/at-home kit |
| Insurance / prior authorization | Self-pay focus; PA support not a stated strength | Self-pay focus; PA support not a stated strength | Prescribers routinely submit PA paperwork when a plan covers weight management |
| Membership pricing | Full total less visible until later in the flow | Bundled price shown earlier in the flow | Sits inside a broader telehealth membership; ask for the GLP-1-specific total |
| Cancellation | Self-service; confirm notice period directly | Self-service; confirm notice period directly | Self-service; confirm notice period directly |
| Best for | Fastest, most self-serve intake | Bundled labs and standing prescriber access | One account for weight management plus other care, or active insurance/PA support |
The Honest Verdict, by Reader Type
If you want the fastest, most self-serve intake and are comfortable with asynchronous messaging instead of a standing clinician relationship, Hims & Hers fits best. If you do not have recent labs and want them bundled into one membership alongside ongoing prescriber access, Ro’s structure removes that separate errand. If you want one telehealth account that covers more than weight management, prefer a live clinician visit, or are actively working an insurance-covered path and want a platform experienced with prior-authorization paperwork, LifeMD’s broader membership is the better structural fit.
None of these differences make the “wrong” choice dangerous — all three, when used correctly, route a qualifying patient to the same category of brand-name medication through the same manufacturer programs. None is a fit for anyone who is pregnant or breastfeeding, has a personal or family history of medullary thyroid carcinoma or MEN2, or has a history of pancreatitis; that combination calls for an in-person physician, and eligibility, dosing, and side-effect decisions on any of these three platforms belong to the prescriber reviewing your case, not to you or to this comparison.
Three Things This Comparison Doesn’t Cover
Product roundups answer which one. They do not answer the questions that come up regardless of which products you choose:
- The full cost and insurance picture — how self-pay compares to an insurance-covered path with a manufacturer savings card, across all three platforms.
- Which drug you actually want — why Wegovy and Ozempic share a molecule but not a price tag or indication.
- What happens after any of the three ships your first dose — the side-effect timeline that is the same regardless of which company wrote the prescription.